Upcoming Events

On September 21st, the Nebraska Hereford Tour will be visiting our farm to look at our breeding program.

On Tuesday, June 24, 2008, Fleischmann Family Farms hosted a group of 41 visitors from Argentina, Brazil and Uruguay along with representatives from Genex, a subsidiary of Cooperative Resources International. This special tour which was hosted by Genex came to the Tim and Anita Fleischmann farm near Osceola to view their bull, RV Stocker 6662 and progeny.

The visitors were on a weeklong tour visiting breeders in Missouri, Nebraska, Iowa, South Dakota, North Dakota and Montana along with Genex facilities in South Dakota and Montana.

The stop at Fleischmann Farms was their only Hereford stop on the tour.

While at the Fleischmann’s, the visitors were able to view and learn about RV Stocker 6662 and his progeny.  Tim and Anita explained to the group the success that they had already seen from this bull.  They currently have calves from RV Stocker 6662 at home and are excited about the light birth weights of under 80 lbs. from their first calf heifers.  The American Hereford Association Spring 2008 Expected Progeny Differences (EPD) analysis recognized RV Stocker 6662 for the following traits in seven categories:  birth weight, weaning weight, yearling weight, scrotal circumference, fat, rib eye area and intramuscular fat.  The visitors were able to ask the Fleischmanns many questions about their farm operation.

Jack Ward, Chief Officer and Director of Breed Improvement of the American Hereford Association spoke to the group and explained to them how using RV Stocker 6662 would be a good match for the cattle operations that they have in their countries.

Following the tour the group was presented a lunch of certified Hereford beef, served by the Osceola FFA chapter, who along with some friends helped the Fleischmanns greet these visitors.

The bull is owned by Fleischmann Family Farms and Ravine Creek Ranch.  They currently have semen for sale, but in the fall, RV Stocker 6662 will be under contract with Genex, who plans to run a series of tests and then sell the semen worldwide.